Healthcare -
Biotechnology - NASDAQ - US
$ 246.27
-1.16 %
$ 31.8 B
Market Cap
-94.0
P/E
ALNY - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss ALNY - Alnylam Pharmaceuticals, Inc.
-23.4 M
LAST VALUE
16.17%
2 YEAR CAGR
6.78%
5 YEAR CAGR
-8.13%
10 YEAR CAGR